Recent Updates

Modified on: 
Nov 13, 2018

This chapter reviews the testing and treatments that are relevant for mothers and their fetuses/infants during pregnancy and postnatally to reduce the risks of hemolytic disease of the fetus and newborn (HDFN) and of immune thrombocytopenias.

Transfusion
Modified on: 
Nov 13, 2018

Platelets are the smallest of the blood cells, with a diameter of two to three microns and no nucleus. Their main function is to mediate primary hemostasis, though they are involved in a number of other processes including primary immunity, tumour progression and inflammation. 

Transfusion
Modified on: 
Nov 7, 2018

Organ and Tissue Donation and Transplantation (OTDT) Advisory Committees

A number of advisory committees and working groups work with Canadian Blood Services on issues and initiatives related to organ donation and transplantation activities. Their work includes providing expert advise and direction on national clinical policy and practice, operational requirements, standardization of procedures, and development of the Canadian Transplant Registry services. These groups also provide input to strategic direction and initiative development and prioritization.

Organs and Tissues
Modified on: 
Nov 5, 2018

NHLAAC provides a forum for improving and standardizing HLA laboratory practices in support of national registries and, in general, organ and tissue donation and transplantation (OTDT) in Canada

Organs and Tissues
Modified on: 
Nov 1, 2018

Molecular immunohematology refers to the detection of the molecular genetic basis of an antigen, rather than the antigen alone.  Use of molecular testing in clinical laboratories requires knowledge of the molecular basis of blood group antigens and the availability of suitable genotyping methods that can be used in our testing environment.

Transfusion
Modified on: 
Oct 25, 2018

We are pleased to provide on a regular basis a Surveillance Report describing infectious disease surveillance that our stakeholders can consult to make evidence-based decisions.

High quality and timely surveillance is key to the safety of the blood supply. This includes monitoring of transmissible disease markers that the blood is tested for (including bacteria), investigation of any reports of possible transfusion transmission, as well as a horizon scan for any new pathogens that may pose a risk now or in the future.

Transfusion
Modified on: 
Oct 25, 2018

The BloodTechNet program was launched in 2011 to facilitate the development of innovative educational resources that support the Transfusion, Cellular Therapy and Transplantation communities in Canada. The program is led by Canadian Blood Services’ Centre for Innovation with financial support from Grifols. For information about the next BloodTechNet program competition, visit blood.ca research funding programs.

Transfusion
Organs and Tissues
Stem Cells
Modified on: 
Oct 25, 2018

The BloodTechNet program was launched in 2011 to facilitate the development of innovative educational resources that support the Transfusion, Cellular Therapy and Transplantation communities in Canada. The program is led by Canadian Blood Services’ Centre for Innovation with financial support from Grifols. For information about the next BloodTechNet program competition, visit blood.ca research funding programs.

Transfusion
Organs and Tissues
Stem Cells
Modified on: 
Oct 25, 2018

The BloodTechNet program was launched in 2011 to facilitate the development of innovative educational resources that support the Transfusion, Cellular Therapy and Transplantation communities in Canada. The program is led by Canadian Blood Services’ Centre for Innovation with financial support from Grifols. For information about the next BloodTechNet program competition, visit blood.ca research funding programs.

Transfusion
Organs and Tissues
Stem Cells

Pages